108 related articles for article (PubMed ID: 17959246)
1. [Is perfusion imaging useful for the characterization of brain tumors?].
Le Bas JF
J Neuroradiol; 2007 Dec; 34(5):287-9. PubMed ID: 17959246
[No Abstract] [Full Text] [Related]
2. [Perfusion MR imaging in brain tumors].
Le Bas JF; Grand S; Krainik A; Lefournier V; Tropres I; Rémy C
J Radiol; 2006 Jun; 87(6 Pt 2):807-21. PubMed ID: 16778749
[TBL] [Abstract][Full Text] [Related]
3. Advanced neuroimaging of pediatric brain tumors: MR diffusion, MR perfusion, and MR spectroscopy.
Poussaint TY; Rodriguez D
Neuroimaging Clin N Am; 2006 Feb; 16(1):169-92, ix. PubMed ID: 16543091
[TBL] [Abstract][Full Text] [Related]
4. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
Neuwelt EA; Várallyay CG; Manninger S; Solymosi D; Haluska M; Hunt MA; Nesbit G; Stevens A; Jerosch-Herold M; Jacobs PM; Hoffman JM
Neurosurgery; 2007 Apr; 60(4):601-11; discussion 611-2. PubMed ID: 17415196
[TBL] [Abstract][Full Text] [Related]
5. Dynamic magnetic resonance perfusion imaging of brain tumors.
Covarrubias DJ; Rosen BR; Lev MH
Oncologist; 2004; 9(5):528-37. PubMed ID: 15477637
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric MR Imaging in the Assessment of Brain Tumors.
Kimura M; da Cruz LCH
Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):87-122. PubMed ID: 26613877
[TBL] [Abstract][Full Text] [Related]
7. Advanced magnetic resonance imaging techniques to evaluate CNS glioma.
Olsen KI; Schroeder P; Corby R; Vucic I; Bardo DM
Expert Rev Neurother; 2005 Nov; 5(6 Suppl):S3-11. PubMed ID: 16274265
[TBL] [Abstract][Full Text] [Related]
8. Primary and metastatic intraaxial brain tumors: prospective comparison of multivoxel 2D chemical-shift imaging (CSI) proton MR spectroscopy, perfusion MRI, and histopathological findings in a group of 159 patients.
Bendini M; Marton E; Feletti A; Rossi S; Curtolo S; Inches I; Ronzon M; Longatti P; Di Paola F
Acta Neurochir (Wien); 2011 Feb; 153(2):403-12. PubMed ID: 21165751
[TBL] [Abstract][Full Text] [Related]
9. Perfusion MR imaging and MR spectroscopy of gemistocytic astrocytoma.
Godefroy A; Derrey S; Laquerrière A; Perot G; Proust F; Gerardin E
J Neuroradiol; 2012 Jul; 39(3):190-4. PubMed ID: 22115534
[TBL] [Abstract][Full Text] [Related]
10. Imaging of brain tumors.
Chourmouzi D; Papadopoulou E; Marias K; Drevelegas A
Surg Oncol Clin N Am; 2014 Oct; 23(4):629-84. PubMed ID: 25246045
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response.
Provenzale JM; Mukundan S; Barboriak DP
Radiology; 2006 Jun; 239(3):632-49. PubMed ID: 16714455
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance perfusion and permeability imaging in brain tumors.
Lacerda S; Law M
Neuroimaging Clin N Am; 2009 Nov; 19(4):527-57. PubMed ID: 19959004
[TBL] [Abstract][Full Text] [Related]
13. Diffusion and perfusion magnetic resonance imaging in brain tumors.
Le Bihan D; Douek P; Argyropoulou M; Turner R; Patronas N; Fulham M
Top Magn Reson Imaging; 1993; 5(1):25-31. PubMed ID: 8416686
[TBL] [Abstract][Full Text] [Related]
14. [Functional imaging of brain tumors].
Aronen HJ; Lundbom N; Haapamäki S; Huttunen J; Korvenoja A; Mäkelä J; Kaste M; Jääskeläinen J
Duodecim; 2000; 116(4):431-42. PubMed ID: 11787095
[No Abstract] [Full Text] [Related]
15. Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors.
Tzika AA; Astrakas LG; Zarifi MK; Zurakowski D; Poussaint TY; Goumnerova L; Tarbell NJ; Black PM
Cancer; 2004 Mar; 100(6):1246-56. PubMed ID: 15022293
[TBL] [Abstract][Full Text] [Related]
16. Perfusion Imaging of Tumefactive Demyelinating Lesions Compared to High Grade Gliomas.
Parks NE; Bhan V; Shankar JJ
Can J Neurol Sci; 2016 Mar; 43(2):316-8. PubMed ID: 26573406
[No Abstract] [Full Text] [Related]
17. [Multimodal magnetic resonance imaging of brain tumors].
Guillevin R; Menuel C; Vallée JN
Rev Neurol (Paris); 2011 Oct; 167(10):704-14. PubMed ID: 21903235
[TBL] [Abstract][Full Text] [Related]
18. Perfusion and permeability MR imaging of gliomas.
Shiroishi MS; Habibi M; Rajderkar D; Yurko C; Go JL; Lerner A; Mogensen MA; Kim PE; Boyko OB; Zee CS; Law M
Technol Cancer Res Treat; 2011 Feb; 10(1):59-71. PubMed ID: 21214289
[TBL] [Abstract][Full Text] [Related]
19. Role of Dynamic Contrast-Enhanced Perfusion Magnetic Resonance Imaging in Grading of Pediatric Brain Tumors on 3T.
Gupta PK; Saini J; Sahoo P; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
Pediatr Neurosurg; 2017; 52(5):298-305. PubMed ID: 28848203
[TBL] [Abstract][Full Text] [Related]
20. [Perfusion magnetic resonance imaging for high grade astrocytomas: Can cerebral blood volume, peak height, and percentage of signal intensity recovery distinguish between progression and pseudoprogression?].
Martínez-Martínez A; Martínez-Bosch J
Radiologia; 2014; 56(1):35-43. PubMed ID: 23790618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
